Cargando…

Soluble LRIG2 is a potential biomarker for type 2 diabetes mellitus

BACKGROUND: Early diagnosis and treatment of type 2 diabetes can delay the onset of microvascular and macrovascular complications. Therefore, the identification of a novel biomarker for diagnosing diabetes is necessary. In the present study, the role of serum soluble leucine-rich repeats and immunog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ji Min, Joung, Kyong Hye, Lee, Jun Choul, Choung, Sorim, Kang, Seon Mee, Kim, Hyun Jin, Ku, Bon Jeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640903/ https://www.ncbi.nlm.nih.gov/pubmed/34926656 http://dx.doi.org/10.21037/atm-21-3272

Ejemplares similares

Serum Soluble Epidermal Growth Factor Receptor Level Increase in Patients Newly Diagnosed with Type 2 Diabetes Mellitus
por: Kim, Ji Min, et al.
Publicado: (2018)

Effect of cholesterol-lowering agents on soluble epidermal growth factor receptor level in type 2 diabetes and hypercholesterolemia
por: Lee, Jun Choul, et al.
Publicado: (2022)

Association between IL-1beta and cardiovascular disease risk in patients with newly diagnosed, drug-naïve type 2 diabetes mellitus: a cross-sectional study
por: Joung, Kyong Hye, et al.
Publicado: (2020)

Serum MIG6 concentration is increased by cholesterol-lowering treatment in patients with type 2 diabetes mellitus and hypercholesterolemia
por: Lee, Jun Choul, et al.
Publicado: (2022)

Clinical Implications of Using Post-Challenge Plasma Glucose Levels for Early Diagnosis of Type 2 Diabetes Mellitus in Older Individuals
por: Joung, Kyong Hye, et al.
Publicado: (2018)

The Role of Circulating Slit2, the One of the Newly Batokines, in Human Diabetes Mellitus
por: Kang, Yea Eun, et al.
Publicado: (2017)

Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice
por: Choung, Sorim, et al.
Publicado: (2019)

Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice
por: Choung, Sorim, et al.
Publicado: (2018)

Amelioration of Hypercholesterolemia by an EGFR Tyrosine Kinase Inhibitor in Mice with Liver-Specific Knockout of Mig-6
por: Lee, Jun Choul, et al.
Publicado: (2014)

A Case of Fulminant Type 1 Diabetes in a Patient with Type 2 Diabetes Mellitus
por: Kim, Ji Min, et al.
Publicado: (2017)

The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2019)

The Association between Type 2 Diabetes Mellitus and Women Cancer: The Epidemiological Evidences and Putative Mechanisms
por: Joung, Kyong Hye, et al.
Publicado: (2015)

Effect of Atorvastatin on Growth Differentiation Factor-15 in Patients with Type 2 Diabetes Mellitus and Dyslipidemia
por: Kim, Ji Min, et al.
Publicado: (2016)

Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2020)

Association between Growth Differentiation Factor 15 (GDF15) and Cardiovascular Risk in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Shin, Min Young, et al.
Publicado: (2016)

Mig-6 Gene Knockout Induces Neointimal Hyperplasia in the Vascular Smooth Muscle Cell
por: Lee, Ju Hee, et al.
Publicado: (2014)

Soluble LRIG2 Ectodomain Is Released from Glioblastoma Cells and Promotes the Proliferation and Inhibits the Apoptosis of Glioblastoma Cells In Vitro and In Vivo in a Similar Manner to the Full-Length LRIG2
por: Xiao, Qungen, et al.
Publicado: (2014)

USP8 modulates ubiquitination of LRIG1 for Met degradation
por: Oh, Young Mi, et al.
Publicado: (2014)

Serum CD14 concentration is associated with obesity and insulin resistance in non-diabetic individuals
por: Kang, Yea Eun, et al.
Publicado: (2022)

Prognostic Value of Erythroblastic Leukemia Viral Oncogene Homolog 2 and Neuregulin 4 in Hepatocellular Carcinoma
por: Rou, Woo Sun, et al.
Publicado: (2023)

LRIG and cancer prognosis
por: Lindquist, David, et al.
Publicado: (2014)

Serum R-Spondin 1 Is a New Surrogate Marker for Obesity and Insulin Resistance
por: Kang, Yea Eun, et al.
Publicado: (2019)

Plasma Adiponectin Levels in Elderly Patients with Prediabetes
por: Kong, Si Eun, et al.
Publicado: (2015)

GDF15 Is a Novel Biomarker for Impaired Fasting Glucose
por: Hong, Jun Hwa, et al.
Publicado: (2014)

A Novel PHEX Gene Mutation in a Patient with Sporadic Hypophosphatemic Rickets
por: Kang, Yea Eun, et al.
Publicado: (2014)

LRIG2 regulates cell proliferation, migration and apoptosis of osteosarcoma
por: Li, Zhi-Qiang, et al.
Publicado: (2022)

Genetic Analysis of CLCN7 in an Old Female Patient with Type II Autosomal Dominant Osteopetrosis
por: Kim, Seon Young, et al.
Publicado: (2018)

Urinary Chiro- and Myo-Inositol Levels as a Biological Marker for Type 2 Diabetes Mellitus
por: Hong, Jun Hwa, et al.
Publicado: (2012)

Increased Pro-Inflammatory T Cells, Senescent T Cells, and Immune-Check Point Molecules in the Placentas of Patients With Gestational Diabetes Mellitus
por: Kang, Yea Eun, et al.
Publicado: (2022)

LRIG2 expression and prognosis in non-small cell lung cancer
por: WANG, GUANGCHUAN, et al.
Publicado: (2014)

Lrig2-Deficient Mice Are Protected against PDGFB-Induced Glioma
por: Rondahl, Veronica, et al.
Publicado: (2013)

The transmembrane protein LRIG2 increases tumor progression in skin carcinogenesis
por: Hoesl, Christine, et al.
Publicado: (2019)

Neurogenic Defects Occur in LRIG2-Associated Urinary Bladder Disease
por: Grenier, Celine, et al.
Publicado: (2023)

A randomized, active-controlled, parallel, open-label, multicenter, phase 4 study to compare the efficacy and safety of pregabalin sustained release tablet and pregabalin immediate release capsule in type II diabetic patients with peripheral neuropathic pain
por: Kang, Seon Mee, et al.
Publicado: (2023)

Addition of Ipragliflozin to Metformin Treatment in Korean Patients with Type 2 Diabetes Mellitus: Subgroup Analysis of a Phase 3 Trial
por: Min, Kyung-Wan, et al.
Publicado: (2017)

Lrig2 and Hpse2, mutated in urofacial syndrome, pattern nerves in the urinary bladder
por: Roberts, Neil A., et al.
Publicado: (2019)

LRIG1 expression and colorectal cancer prognosis
por: Bakherad, Maryam, et al.
Publicado: (2021)

The Prognostic Role of LRIG Proteins in Endometrial Cancer
por: Razumova, Zoia, et al.
Publicado: (2021)

The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status
por: Johansson, Mikael, et al.
Publicado: (2013)

Asymptomatic Secondary Aortoduodenal Fistula Incidentally Diagnosed During a Health Check-up: A Case Report
por: Park, Sang Ki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r1btch4dkubi9807lrsjof5j44